News

Acrongenomics Inc., a Swiss life science venture company and Molecular Vision Ltd., a spin-out from the Imperial College London, said they have signed a memorandum of understanding to jointly develop diagnostic devices for diabetes, drug abuse, STDs and cardiovascular diseases.

In a funk after years of stagnation and high unemployment, Germany is looking to an unlikely alliance between football and R&D to kick start the economy.

An Israeli academic has developed a virtual reality device to help people with neurodegenerative diseases to improve their walking. He is now seeking funding of about $500,000 to commercialise it and looking for manufacturing partner.

How do you take a pill before you wake up? Denmark's Egalet has found an answer, and is looking for partners to help develop it.

A Linköpings Tekniska Högskola spin-out has developed plug-in devices for the direct production of 3D animations. The company is now looking for a first private funding round.

A new wave of companies with rich backers plans to change how people interact over the Internet. But sceptics are still searching for a sustainable business model.

Sweden is ranked number one among 31 European nations for its spending on R&D - but it is still looking for its first home-grown biotechnology product.

Philippe Pouletty is on a roll. One by one, the serial entrepreneur with a penchant for provocative lobbying is seeing his ideas become official French policy. But not everyone is pleased.

A small UK charity has turned entrepreneur to develop a low cost, mass manufactured, modern device to pump the blood of people whose heart muscle is failing.

The UK budget last week set out measures to extract more value, improve quality and increase innovation from the billions the government spends on science. Nuala Moran looks into the small print.